Clinical Trials

Find a Trial

Trial Summary

Principal InvestigatorPradhan, Kamnesh
Age GroupChildren
TitleKey Adverse Events Following Childhood Cancer
DescriptionThis clinical trial is studying cancer survivors to identify those who are at increased risk of developing late-occurring complications after undergoing treatment for childhood cancer. A patient's genes may affect the risk of developing complications, such as congestive heart failure, heart attack, stroke, and second cancer, years after undergoing cancer treatment. Genetic studies may help doctors identify survivors of childhood cancer who are more likely to develop late complications.
Key EligibilityIn order to be eligible to take part in this trial, patients must meet the following criteria:

  • Be 21 years of age or younger
  • Have a diagnosis of primary cancer at age 21 or younger, irrespective of current age
  • No prior history of allogeneic (non-autologous) hematopoietic cell transplant
For a full list of participation criteria, please visit
Applicable Disease SitesBrain Tumors (Child)
Childhood Cancers
Ewing's Sarcoma (Child)
Germ Cell Tumor (Child)
Leukemia (Child)
Lymphoma, Hodgkin's (Child)
Lymphoma, Non-Hodgkin's (Child)
Neuroblastoma (Child)
Retinoblastoma (Child)
Rhabdomyosarcoma (Child)
Soft Tissue Sarcoma (Child)
Wilms' Tumor (Child)
Participating InstitutionsIndiana University (IU)
  • Indiana University Hospital / IU Simon Cancer Center
  • Riley Hospital for Children
Treatment TypeOther
ContactMelissa Lee, Phone: +1 317-944-4281